Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien Li

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Hepatology|February 5, 2013
Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failureVairappan Balasubramaniyan, Dipok Kumar Dhar, Anne E Warner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 27, 2023
HLA-DRB1*15:01 and the <i>MERTK</i> Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MSMichele D Binder, Eze C Nwoke, Ellen Morwitch, et al.
Neurology|March 24, 2022
Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple SclerosisVivien Li, Baptiste Leurent, Frederik Barkhof, et al.
BMJ Neurology Open|March 8, 2021
Cerebrospinal fluid cannot be used to distinguish inflammatory myelitis from congestive myelopathy due to spinal dural arteriovenous fistula: case seriesVinojini Vivekanandam, Vivien Li, Teddy Wu, et al.
Multiple Sclerosis and Related Disorders|September 21, 2020
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in AustraliaNabil Seery, Vivien Li, Ai-Lan Nguyen, et al.
Annals of the Academy of Medicine, Singapore|June 21, 2024
Minimal monitoring is a safe but underutilised strategy for hepatitis C virus management in SingaporeWei Xuan Tay, Samantha Jingyun Koh, Francis Kok Ban Teh, et al.
CNS Drugs|April 13, 2021
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort StudyNabil Seery, Sifat Sharmin, Vivien Li, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
CNS Drugs|January 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic ApproachVivien Li, Fiona C McKay, David C Tscharke, et al.
BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|February 5, 2013
Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failureVairappan Balasubramaniyan, Dipok Kumar Dhar, Anne E Warner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 27, 2023
HLA-DRB1*15:01 and the <i>MERTK</i> Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MSMichele D Binder, Eze C Nwoke, Ellen Morwitch, et al.
Neurology|March 24, 2022
Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple SclerosisVivien Li, Baptiste Leurent, Frederik Barkhof, et al.
BMJ Neurology Open|March 8, 2021
Cerebrospinal fluid cannot be used to distinguish inflammatory myelitis from congestive myelopathy due to spinal dural arteriovenous fistula: case seriesVinojini Vivekanandam, Vivien Li, Teddy Wu, et al.
Multiple Sclerosis and Related Disorders|September 21, 2020
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in AustraliaNabil Seery, Vivien Li, Ai-Lan Nguyen, et al.
Annals of the Academy of Medicine, Singapore|June 21, 2024
Minimal monitoring is a safe but underutilised strategy for hepatitis C virus management in SingaporeWei Xuan Tay, Samantha Jingyun Koh, Francis Kok Ban Teh, et al.
CNS Drugs|April 13, 2021
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort StudyNabil Seery, Sifat Sharmin, Vivien Li, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
CNS Drugs|January 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic ApproachVivien Li, Fiona C McKay, David C Tscharke, et al.
BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.
Pageof 4